Mahesh Asawa Chandra

Director/Board Member at Unidrug Innovative Pharma Technologies Ltd.

76 year

Consumer Services

Health Technology

Profile

Mahesh Asawa Chandra is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and a Fellow Member at The Institute of Chartered Accountants of India.
He has an undergraduate and graduate degree from Devi Ahilya University.

Mahesh Asawa Chandra active positions

Companies	Position	Start
Unidrug Innovative Pharma Technologies Ltd. Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India.	Director/Board Member	2018-09-19
The Institute of Chartered Accountants of India	Corporate Officer/Principal	-

All active positions of Mahesh Asawa Chandra

Training of Mahesh Asawa Chandra

Devi Ahilya University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mahesh Asawa Chandra's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Unidrug Innovative Pharma Technologies Ltd. Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India.	Health Technology